General Announcement::Announcement of the Results of the Offer

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
27-Mar-2021 12:34:27
Status
New
Announcement Sub Title
Announcement of the Results of the Offer
Announcement Reference
SG210327OTHRYN28
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary and Compliance Officer
Description (Please provide a detailed description of the event in the box below)
Announcement of the Results of the Offer in respect of U.S.$200,000,000 2.00 per cent. Resettable Onward Starting Equity-linked Securities Due 2022 issued by Glenmark Pharmaceuticals Limited

Attachments

SGX_Tender Results Announcement.pdf
Total size =31K